Hanmi Pharm. Co., Ltd. (KRX:128940)
South Korea · Delayed Price · Currency is KRW 480,500
-53,500 (-10.02%)
At close: Oct 8, 2026
Hanmi Pharm. Market Cap
Hanmi Pharm. has a market cap or net worth of 6.1 trillion as of October 9, 2026. It is the 3,932nd most valuable company in the world and the 97th biggest in South Korea. Its market cap has increased by 35.64% in one year.
Market Cap
6.10T
Enterprise Value
6.29T
Revenue
1.66T
Global Rank
Country Rank
#97 South Korea
PE Ratio
28.10
ChartMarket Cap Chart
Since July 30, 2010, Hanmi Pharm.'s market cap has increased from 680.70B to 6.10T, an increase of 795.72%. That is a compound annual growth rate of 14.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 6.10T | 6.38% |
| Dec 30, 2025 | 5.73T | 61.14% |
| Dec 30, 2024 | 3.56T | -20.49% |
| Dec 28, 2023 | 4.47T | 20.54% |
| Dec 29, 2022 | 3.71T | 10.00% |
| Dec 30, 2021 | 3.37T | -23.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Yuhan | 5.51T |
| Hanall Biopharma | 2.26T |
| Celltrion Pharm | 1.73T |
| GC Biopharma | 1.47T |
| Daewoong Pharmaceutical | 1.26T |
| Chong Kun Dang Pharmaceutical | 865.67B |
| Boryung | 727.69B |
| Daewoong | 648.21B |